Sunshine Biopharma SBFM
NASDAQ SBFM
$0.15 -0.02 (-10.18%)
At close: Oct 23, 2026 · 4:00 PM EDT

Sunshine Biopharma (SBFM) Gains from Sales and Divestitures (2018 - 2025)

Updated

Sunshine Biopharma (SBFM) reported Gains from Sales and Divestitures of -$582,237 for FY2019.

Analysis

Sunshine Biopharma (SBFM) Gains from Sales and Divestitures (2018 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Sunshine Biopharma 188,824.31 -38.90 Mn 2.43 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -7.00
Jun 30, 2019 -580,125.00
Mar 31, 2019 -2,112.00
Dec 31, 2018 8,847.00
Sep 30, 2018 5,278.00
Jun 30, 2018 5,413.00
API Access

Sunshine Biopharma Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=SBFM&period=max&api_key=YOUR_API_KEY